Central versus Low-Lying Umbilical Venous Catheters: A Multicenter Study of Practices and Complications

Am J Perinatol. 2019 Sep;36(11):1198-1204. doi: 10.1055/s-0038-1676482. Epub 2018 Dec 19.

Abstract

Objectives: Conventional neonatology practice is to place umbilical venous catheters (UVCs) in central position and to limit the use of low-lying catheters. Our objectives were to describe the practices and complications associated with UVCs and to evaluate the type of infusates used with either UVC position.

Study design: A retrospective chart review was performed at four neonatal intensive care units to identify neonates who underwent UVC placement over a 2-year period. Infant demographics, UVC position, catheter days, fluid and medication characteristics, and specific complications were extracted.

Results: A total of 2,011 neonates who underwent UVC placement were identified during the 2-year period. Of these, 641 UVCs (31.9%) were identified in the low-lying position. Centrally positioned UVCs were associated with lower gestational age and were left in situ for a longer duration than low-lying UVCs. Infusions of hyperosmolar solutions and vasopressors were significantly higher in central UVCs, though they were used in a significant number of low-lying UVCs. Complications, while not statistically different, were three times higher in low-lying UVCs.

Conclusion: Despite conventional teaching, low-lying UVCs were used in nearly one-third of infants in this cohort. Parenteral nutrition, antibiotics, and vasopressors were infused through central and low-lying UVCs. There was no statistically significant difference in complication rates between UVC positions.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Catheterization, Peripheral / adverse effects
  • Catheterization, Peripheral / methods*
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Parenteral Nutrition
  • Practice Patterns, Physicians'*
  • Retrospective Studies
  • Umbilical Veins*
  • Vascular Access Devices*
  • Vasoconstrictor Agents / administration & dosage

Substances

  • Anti-Bacterial Agents
  • Vasoconstrictor Agents